Skip to main content Accessibility help
×
Home
  • Print publication year: 2011
  • Online publication date: August 2011

18 - Unusual gait disorders

References

1. Thompson PD, Nutt JG. Higher level gait disorders. J Neural Transm 2007; 114: 1305–7.
2. Ropper AH, Brown RH. Disorders of stance and gait. In: Ropper AH, Brown RH, eds. Adams and Victor’s Principles of Neurology. 8th ed. New York: McGraw-Hill; 2008: 100–8.
3. Murray MP, Drought AB, Kory RC. Walking patterns of normal men. J Bone Joint Surg Am 1964; 46: 335–60.
4. Murray MP, Kory RC, Sepic SB. Walking patterns of normal women. Arch Phys Med Rehabil 1970; 51: 637–50.
5. Winter DA, Patla AE, Frank JS, Walt SE. Biomechanical walking pattern changes in the fit and healthy elderly. Phys Ther 1990; 70: 340–7.
6. Nutt JG, Marsden CD, Thompson PD. Human walking and higher-level gait disorders, particularly in the elderly. Neurology 1993; 43: 268–79.
7. Winter DA. Human balance and posture control during standing and walking. Gait Posture 1995; 3: 193–214.
8. Tyrrell, PJ. Apraxia of gait or higher level gait disorders: review and description of two cases of progressive gait disturbance due to frontal lobe degeneration. J R Soc Med 1994; 87: 454–6.
9. Deliagina TG, Orlovsky GN. Comparative neurobiology of postural control. Curr Opin Neurobiol 2002; 12: 652–7.
10. Armstrong, DM. The supraspinal control of mammalian locomotion. J Phys 1988; 102: 2–13.
11. Massion, J. Postural control systems in developmental perspective. Neurosci Biobehav Rev 1998; 22: 465–72.
12. Elble RJ, Moody C, Leffler K, Sinha R. The initiation of normal walking. Mov Dis 1994; 9: 139–46.
13. MacKinnon CD, Winter DA. Control of whole body balance in the frontal plane during human walking. J Biomech 1993; 26: 633–44.
14. Borghese NA, Bianchi L, Lacquanti F. Kinematic determinants of human locomotion. J Physiol 1996; 494: 863–79.
15. Zehr EP, Duysens J. Regulation of arm and leg movement during human locomotion. Neuroscientist 2004; 10: 347–61.
16. Mori S, Matsuyama K, Mori F, Nakajima K. Supraspinal sites that induce locomotion in the vertebrate central nervous system. Adv Neurol 2001; 87: 25–40.
17. Murray MP, Sepic SB, Gardner GM, Downs WJ. Walking patterns of men with parkinsonism. Am J Phys Med 1978; 57: 278–94.
18. Vieregge P, Stolze H, Klein C, Heberlein L. Gait quantitation in Parkinson’s disease: locomotor disability and correlation to clinical scales J Neural Transm 1997; 104: 237–48.
19. Bloem BR, Grimbergen YA, Cramer M, Willemsen M, Zwinderman AH. Prospective assessment of falls in Parkinson’s disease. J Neurol 2001; 248: 950–8.
20. Abdo WF, Borm GF, Munneke M et al. Ten steps to identify atypical parkinsonism. J Neurol Neurosurg Psychiatry 2006; 77: 1367–9.
21. Knutsson E. An analysis of Parkinsonian gait. Brain 1972; 95: 475–86.
22. Morris M, Iansek R, Matyas T, Summers J. Abnormalities in the stride length-cadence relation in parkinsonian gait. Mov Dis 1998; 13: 61–9.
23. Crenna P, Carpinella I, Rabuffetti M et al. The association between impaired turning and normal straight walking in Parkinson’s disease. Gait Posture 2007; 26: 172–8.
24. Patla AE, Prentice SD, Rietdyk S, Allard F, Martin C. What guides the selection of alternate foot placement during locomotion in humans. Exp Brain Res 1999; 128: 441–50.
25. Giladi N, Treves TA, Simon ES et al. Freezing of gait in patients with advanced Parkinson’s disease. J Neural Transm 2001; 108: 53–61.
26. Giladi N, McDermott MP, Fahn S et al. Freezing of gait in PD: prospective assessment in the DATATOP cohort. Neurology 2001; 56: 1712–21.
27. Stolze H, Klebe S, Petersen G, Raethjen J et al. Typical features of cerebellar ataxic gait. J Neurol Neurosurg Psychiatry 2002; 73: 310–2.
28. Palliyath S, Hallett M, Thomas SL. Lebiedowska MK. Gait in patients with cerebellar ataxia. Mov Disord 1998; 13: 958–64.
29. Dietz V. Neurophysiology of gait disorders: present and future applications. Electroencephalogr Clin Neurophysiol 1997; 103: 333–55.
30. Elble RJ, Thomas SS, Higgins C, Colliver J. Stride-dependent changes in gait of older people. J Neurol 1991; 238: 1–5.
31. Lajoie Y, Barbeau H, Hamelin M. Attentional requirements of walking in spinal cord injured patients compared to normal subjects. Spinal Cord 1999; 37: 245–50.
32. Thompson PD, Marsden CD. Gait disorder of subcortical arteriosclerotic encephalopathy: Binswanger’s disease. Mov Disord 1987; 2: 1–8.
33. Zijlmans JC, Poels PJ, Duysens J et al. Quantitative gait analysis in patients with vascular parkinsonism. Mov Disord 1996; 11: 501–8.
34. Zijlmans JC, Thijssen HO, Vogels OJ et al. Neurology 1995; 45: 2183–8.
35. Zijlmans JC, Daniel SE, Hughes AJ, Revesz T, Lees AJ. Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord 2004; 19: 630–40.
36. Mevawalla N, Fung V, Morris J, Halliday GM. Unilateral rest tremor in vascular parkinsonism associated with a contralateral lesion of the locus ceruleus. Mov Disord 2009; 24: 1242–4.
37. Stolze H, Kuhtz-Buschbeck JP, Drucke H et al. Gait analysis in idiopathic normal pressure hydrocephalus – which parameters respond to the CSF tap test? Clin Neurophysiol 2000; 11: 1678–86.
38. Stolze H, Khutz-Buschbeck JP, Drucke J, Johnk K, Illert M, Deuschl G. Comparative analysis of the gait disorder of normal pressure hydrocephalus and Parkinson’s disease. J Neurol Neurosurg Pyshciatry 2001; 70: 289–97.
39. Vanneste JA. Three decades of normal pressure hydrocephalus: are we wiser now? J Neurol Neurosurg Psychiatry 1994; 57: 1021–5.
40. Marmarou A, Bergsneider M, Klinge P, Relkin N, Black PM. The value of supplemental prognostic tests for the preoperative assessment of idiopathic normal-pressure hydrocephalus. Neurosurgery 2005; 57(Suppl 3): S17–28.
41. Nadeau SE. Gait apraxia: further clues to localization. Eur Neurol 2007; 58(3): 142–5.
42. Rossor MN, Tyrrell PJ, Warrington EK, Thompson PD, Marsden CD, Lantos P. Progressive frontal gait disturbance with atypical Alzheimer’s disease and corticobasal degeneration. J Neurol Neurosurg Psychiatry 1999; 67: 345–52.
43. Wenning GK, Litvan I, Jankovic J et al. Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry 1998; 64: 184–9.
44. Nath U, Ben-Shlomo Y, Thomson RG, Lees AJ, Burn DJ. Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study. Neurology 2003; 60: 910–6.
45. Rinne JO, Lee MS, Thompson PD, Marsden CD. Corticobasal degeneration: a clinical study of 36 cases. Brain 1994; 117: 1183–96.
46. Litvan I, Agid Y, Goetz C et al. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology 1997; 48: 119–25.
47. Wenning GK, Tison F, Ben Shlomo Y, Daniel SE, Quinn NP. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 1997; 12: 133–47.
48. Kollensperger M, Geser F, Seppi K et al. Red flags for multiple system atrophy. Mov Disord 2008; 23: 1093–9.
49. Muller J, Seppi K, Stefanova N, Poewe W, Litvan I, Wenning GK. Freezing of gait in postmortem-confirmed atypical parkinsonism. Mov Disord 2002; 17: 1041–5.
50. Williams DR, Holton JL, Strand K, Revesz T, Lees AJ. Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy. Mov Disord 2007; 22: 2235–41.
51. Fife TD, Baloh RW. Disequilibrium of unknown cause in older people. Ann Neurol 1993; 34: 694–702.
52. Sudarsky L, Ronthal M. Gait disorders among elderly patients. A survey study of 50 patients. Arch Neurol 1983; 40: 740–3.
53. Thompson PD. Higher level gait disorders. Curr Neurol Neurosci Rep 2007; 7: 290–4.
54. Bruns L. Uber storungen des gleichgewichts bei stirnhirntumoren. Dtsch Med Wschr 1892; 18: 138–43.
55. Meyer JS, Barron DW. Apraxia of gait: A clinico-physiological study. Brain 1960; 83: 261–84.
56. Zadikoff C, Lang AE. Apraxia in movement disorders. Brain 2005; 128(Pt 7): 1480–97.
57. Jankovic J. Dystonic disorders. In: Jankovic J, Tolosa E, eds. Parkinson’s Disease and Movement Disorders. 5th ed. Philadelphia: Lippincott Williams and Wilkins; 2007: 321–47.
58. Berardelli A, Rothwell JC, Hallett M, Thompson PD, Manfredi M, Marsden CD. The pathophysiology of primary dystonia. Brain 1998; 121(Pt 7): 1195–212.
59. Albanese A. The clinical expression of primary dystonia. J Neurol 2003; 250: 1145–51.
60. Schneider SA, Edwards MJ, Grill SE et al. Adult-onset primary lower limb dystonia. Mov Disord 2006; 21(6): 767–71.
61. Nygaard TG, Marsden CD, Duvoisin RC. Dopa-responsive dystonia. Adv Neurol 1988; 50: 377–84.
62. Chaila EC, McCabe DJH, Delanty N, Costello DJ, Murphy RP. Broadening the phenotype of childhood-onset dopa-responsive dystonia. Arch Neurol 2006; 63(8): 1185–8.
63. Micheli F, Pardal MM. Dopa-responsive dystonic camptocormia. Neurology 2007; 68(18): 1543.
64. Van Gerpen, JA. Dopa-responsive dystonic camptocormia. Neurology 2006; 66: 1779.
65. Kong CK, Ko CH, Tong SF, Lam CW. Atypical presentation of dopa-responsive dystonia: generalized hypotonia and proximal weakness. Neurology 2001; 57: 1121–4.
66. Uc EY, Rodnitzky RL. Childhood dystonia. Semin Pediatr Neurol 2003; 10: 52–61.
67. Tassin J, Durr A, Bonnet AM et al. Levodopa-responsive dystonia. GTP cyclohydrolase I or parkin mutations? Brain 2000; 123: 1112–21.
68. Koller WC, Trimble J. The gait abnormality of Huntington’s disease. Neurology 1985; 35: 1450–4.
69. Grimbergen YAM, Knol MJ, Bloem BR, Kremer BPH, Roos RAC, Munneke M. Falls and gait disturbances in Huntington’s disease. Mov Disord 2008; 23: 970–6.
70. Danek A, Walker RH. Neuroacanthocytosis. Curr Opin Neurol 2005; 18: 386–92.
71. Danek A, Dobson-Stone C, Velayos-Baeza A. The phenotype of chorea-acanthocytosis: a review of 106 patients with VPS13A mutations. Mov Disord 2005; 20: 1678.
72. Stevenson VL, Hardie RJ. Acantocytosis and neurological disroders. J Neurol 2001; 248: 87–94.
73. Hardie RJ, Pullon HW, Harding AE et al. Brain 1991; 114: 13–49.
74. Tsai CH, Chen RS, Chang HC, Lu CS, Liao KK. Acanthocytosis and spinocerebellar degeneration: a new association? Mov Disord 1997; 12: 456–9.
75. Jung HH. McLeod syndrome: clinical and neuroradiological aspects. Mov Disord 2005; 20: 1673–94.
76. Deuschl G, Bain P, Brin M. Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Mov Disord 1998; 13(Suppl 3): 2–23.
77. Lance JW, Adams RD. The syndrome of intention or action myoclonus as a sequel to hypoxic encephalopathy. Brain 1963; 86: 111–36.
78. Obeso JA, Artieda J, Burleigh A. Clinical aspects of negative myoclonus. Adv Neurol 1995; 67: 1–7.
79. Marsden CD, Harding AE, Obeso JA, Lu CS. Progressive myoclonic ataxia (the Ramsay Hunt syndrome). Arch Neurol 1990; 47: 1121–5.
80. Marsden CD, Obeso JA. The Ramsay Hunt syndrome is a useful clinical entity. Mov Disord 1989; 4: 6–12.
81. Armand S, Mercier M, Watelain E et al. A comparison of gait in spinal muscular atrophy, type II and Duchenne muscular dystrophy. Gait Posture 2005; 21: 369–78.
82. Amato AA, Gronseth GS, Jackson CE et al. Inclusion body myositis: clinical and pathological boundaries. Ann Neurol 1996; 40: 581–6.
83. Needham M, Mastaglia FL. Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches. Lancet Neurol 2007; 6: 620–31.
84. Dabby R, Lange DJ, Trojaborg W, et al. Inclusion body myositis mimicking motor neuron disease. Arch Neurol 2001; 58: 1253–6.
85. Ertan S, Uluduz D, Ozekmekci S et al. Clinical characteristics of 49 patients with psychogenic movement disorders in a tertiary clinic in Turkey. Mov Disord 2009; 24: 759–62.
86. Baik JS, Lang AE. Gait abnormalities in psychogenic movement disorders. Mov Disord 2007; 22: 395–9.
87. Sudarsky L. Psychogenic gait disorders. Semin Neurol 2006; 26: 351–6.
88. Lempert T, Brandt T, Dieterich M, Huppert D. How to identify psychogenic disorders of stance and gait. A video study in 37 patients. J Neurol 199; 238: 140–6.
89. Hayes MW, Graham S, Heldorf P, de Moore G, Morris JG. A video review of the diagnosis of psychogenic gait: appendix and commentary. Mov Disord 1999; 14: 914–21.
90. Okun MS, Rodriguez RL, Foote KD, Fernandez HH. The “chair test” to aid in the diagnosis of psychogenic gait disorders. Neurology 2007; 13: 87–91.
91. Gupta A, Lang AE. Psychogenic movement disorders. Curr Opin Neurol 2009; 22: 430–6.